Bleomycin-induced reversible acute interstitial pneumonia

O. Balaji, D. Amita, Navin Patil, Joseph Thomas

Research output: Contribution to journalArticle

Abstract

As of now, about 380 medications are implicated in causing respiratory reactions and most common among that is drug-induced interstitial disease. Oral, parental as well inhalational drugs are known to cause drug-induced interstitial lung disease. Bleomycin is a chemotherapeutic agent used in the treatment of lymphomas, germ cell tumors of the testes. Most common pulmonary toxicity is diffuse alveolar damage with nonspecific interstitial pneumonitis being next. We report a case of bleomycin-induced reversible acute interstitial pneumonia in a Hodgkin’s lymphoma patient with adriamycin, bleomycin, vinblastine, dacarbazine regimen. Causality assessment was done using Naranjo scale, and probable causal relationship was established. Adverse drug reaction was found to be moderately severe and not preventable as per Hartwig’s severity and Thornton’s preventability scaling respectively.

Original languageEnglish
Pages (from-to)6-8
Number of pages3
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume10
Issue number5
DOIs
Publication statusPublished - 01-01-2017

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Bleomycin-induced reversible acute interstitial pneumonia'. Together they form a unique fingerprint.

  • Cite this